"We are honored and excited to have Jon Saxe join our board," said Evan Unger MD, President and CEO of NuvOx. "His broad knowledge of the industry and years of experience both as an executive and in corporate governance will serve NuvOx well as it continues to grow in the coming years. The other members of the board and I are very much looking forward to working with him." Click here to read more.
top of page
Recent PostsSee All
NuvOx Receives SPAN Grant to Conduct Late-stage Preclinical Studies of Putative Neuroprotectants Combined with Reperfusion Tucson, AZ, April 17th, 2023 - NuvOx Pharma (NuvOx), a clinical stage biotec
bottom of page